Document:

EX-10.2

 Exhibit 10.2 

INDEMNITY AGREEMENT 
 This
Indemnity Agreement, dated as of                     , 2016 is made by and between KalVista Pharmaceuticals, Inc., a Delaware corporation (the
“Company”), and                     , a director, officer or key employee of the Company or one of the Company’s
subsidiaries or other service provider who satisfies the definition of Indemnifiable Person set forth below (“Indemnitee”). 

RECITALS 
 A.
    The Company is aware that competent and experienced persons are increasingly reluctant to serve as representatives of corporations unless they are protected by comprehensive liability insurance and indemnification, due to
increased exposure to litigation costs and risks resulting from their service to such corporations, and due to the fact that the exposure frequently bears no relationship to the compensation of such representatives; 

B.     The members of the Board of Directors of the Company (the “Board”) have concluded that to
retain and attract talented and experienced individuals to serve as representatives of the Company and its Subsidiaries and Affiliates and to encourage such individuals to take the business risks necessary for the success of the Company and its
Subsidiaries and Affiliates, it is necessary for the Company to contractually indemnify certain of its representatives and the representatives of its Subsidiaries and Affiliates, and to assume for itself maximum liability for Expenses and Other
Liabilities in connection with claims against such representatives in connection with their service to the Company and its Subsidiaries and Affiliates; 

C.     Section 145 of the Delaware General Corporation Law (“Section 145”), empowers the Company
to indemnify by agreement its officers, directors, employees and agents, and persons who serve, at the request of the Company, as directors, officers, employees or agents of other corporations, partnerships, joint ventures, trusts or other
enterprises, and expressly provides that the indemnification provided thereby is not exclusive; and 
 D.     The
Company desires and has requested Indemnitee to serve or continue to serve as a representative of the Company and/or the Subsidiaries or Affiliates of the Company free from undue concern about inappropriate claims for damages arising out of or
related to such services to the Company and/or the Subsidiaries or Affiliates of the Company. 
 AGREEMENT 

NOW, THEREFORE, the parties hereto, intending to be legally bound, hereby agree as follows: 

1.     Definitions. 

(a)    Affiliate. For purposes of this Agreement, “Affiliate” of the Company
means any corporation, partnership, limited liability company, joint venture, trust or other enterprise in respect of which Indemnitee is or was or will be serving as a director, officer, trustee, 

 
manager, member, partner, employee, agent, attorney, consultant, member of the entity’s governing body (whether constituted as a board of directors, board of managers, general partner or
otherwise), fiduciary, or in any other similar capacity at the request, election or direction of the Company, and including, but not limited to, any employee benefit plan of the Company or a Subsidiary or Affiliate of the Company.

(b)    Change in Control. For purposes of this Agreement, “Change in Control”
means (i) any “person” (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended), other than a Subsidiary or a trustee or other fiduciary holding securities under an employee benefit plan of the
Company or Subsidiary, is or becomes the “Beneficial Owner” (as defined in Rule 13d-3 under said Act), directly or indirectly, of securities of the Company representing 50% or more of the total voting power represented by the
Company’s then outstanding capital stock or (ii) during any period of two consecutive years, individuals who at the beginning of such period constitute the Board and any new director whose election by the Board or nomination for election by the
Company’s stockholders was approved by a vote of at least two-thirds (2/3) of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved,
cease for any reason to constitute a majority thereof, or (iii) the stockholders of the Company approve a merger or consolidation of the Company with any other corporation, other than a merger or consolidation that would result in the outstanding
capital stock of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into capital stock of the surviving entity) at least 80% of the total voting power represented by the
capital stock of the Company or such surviving entity outstanding immediately after such merger or consolidation, or the stockholders of the Company approve a plan of complete liquidation of the Company or an agreement for the sale or disposition by
the Company (in one transaction or a series of transactions) of all or substantially all of the Company’s assets. 

(c)    Expenses. For purposes of this Agreement, “Expenses” means all direct
and indirect costs of any type or nature whatsoever (including, without limitation, all attorneys’ fees and related disbursements, and other out-of-pocket costs), paid or incurred by Indemnitee in connection with either the investigation,
defense or appeal of, or being a witness in, a Proceeding, or establishing or enforcing a right to indemnification under this Agreement, Section 145 or otherwise; provided, however, that Expenses shall not include any judgments, fines, ERISA excise
taxes or penalties or amounts paid in settlement of a Proceeding. 
 (d)    Indemnifiable Event. For
purposes of this Agreement, “Indemnifiable Event” means any event or occurrence related to Indemnitee’s service for the Company or any Subsidiary or Affiliate as an Indemnifiable Person (as defined below), or by reason
of anything done or not done, or any act or omission, by Indemnitee in any such capacity. 

(e)    Indemnifiable Person. For the purposes of this Agreement, “Indemnifiable
Person” means any person who is or was a director, officer, trustee, manager, member, partner, employee, attorney, consultant, member of an entity’s governing body (whether constituted as a board of directors, board of managers,
general partner or otherwise) or other agent or fiduciary of the Company or a Subsidiary or Affiliate of the Company.

  
 2 

 (f)    Independent Counsel. For purposes of this
Agreement, “Independent Counsel” means legal counsel that has not performed services for the Company or Indemnitee in the five years preceding the time in question and that would not, under applicable standards of
professional conduct, have a conflict of interest in representing either the Company or Indemnitee. 

(g)    Independent Director. For purposes of this Agreement, “Independent
Director” means a member of the Board who is not a party to the Proceeding for which a claim is made under this Agreement. 

(h)    Other Liabilities. For purposes of this Agreement, “Other Liabilities”
means any and all liabilities of any type whatsoever (including, but not limited to, judgments, fines, penalties, ERISA (or other benefit plan related) excise taxes or penalties, and amounts paid in settlement and all interest, taxes, assessments
and other charges paid or payable in connection with or in respect of any such judgments, fines, ERISA (or other benefit plan related) excise taxes or penalties, or amounts paid in settlement). 

(i)    Proceeding. For the purposes of this Agreement, “Proceeding” means any
threatened, pending, or completed action, suit or other proceeding, whether civil, criminal, administrative, investigative, legislative or any other type whatsoever, preliminary, informal or formal, including any arbitration or other alternative
dispute resolution and including any appeal of any of the foregoing. 
 (j)    Subsidiary. For
purposes of this Agreement, “Subsidiary” means any entity of which more than 50% of the outstanding voting securities is owned directly or indirectly by the Company. 

2.    Agreement to Serve. The Indemnitee agrees to serve and/or continue to serve as an Indemnifiable
Person in the capacity or capacities in which Indemnitee currently serves the Company as an Indemnifiable Person, and any additional capacity in which Indemnitee may agree to serve, until such time as Indemnitee’s service in a particular
capacity shall end according to the terms of an agreement, the Company’s Certificate of Incorporation or Bylaws, governing law, or otherwise. Nothing contained in this Agreement is intended to create any right to continued employment or
other form of service for the Company or a Subsidiary or Affiliate of the Company by Indemnitee. 

3.    Mandatory Indemnification.

(a)    Agreement to Indemnify. In the event Indemnitee is a person who was or is a party to or witness
in or is threatened to be made a party to or witness in any Proceeding by reason of an Indemnifiable Event, the Company shall indemnify Indemnitee from and against any and all Expenses and Other Liabilities incurred by Indemnitee in connection with
(including in preparation for) such Proceeding to the fullest extent not prohibited by the Delaware General Corporation Law (“DGCL”), as the same may be amended from time to time (but only to the extent that such amendment
permits the Company to provide broader indemnification rights than the DGCL permitted prior to the adoption of such amendment). 

  
 3 

 (b)    Exception for Amounts Covered by Insurance and Other
Sources. Notwithstanding the foregoing, the Company shall not be obligated to indemnify Indemnitee for Expenses or Other Liabilities of any type whatsoever (including, but not limited to judgments, fines, penalties, ERISA excise taxes or
penalties and amounts paid in settlement) to the extent such have been paid directly to Indemnitee (or paid directly to a third party on Indemnitee’s behalf) by any directors and officers, or other type, of insurance maintained by the
Company.
 (c)    Company Obligations Primary. The Company hereby acknowledges that Indemnitee may
have rights to indemnification for Expenses and Other Liabilities provided by [name of VC fund or other sponsoring organization (“Other Indemnitor”)]. The Company agrees with Indemnitee that the Company is the indemnitor
of first resort of Indemnitee with respect to matters for which indemnification is provided under this Agreement and that the Company will be obligated to make all payments due to or for the benefit of Indemnitee under this Agreement without regard
to any rights that Indemnitee may have against the Other Indemnitor. The Company hereby waives any equitable rights to contribution or indemnification from the Other Indemnitor in respect of any amounts paid to Indemnitee hereunder. The
Company further agrees that no reimbursement of Other Liabilities or payment of Expenses by the Other Indemnitor to or for the benefit of Indemnitee shall affect the obligations of the Company hereunder, and that the Company shall be obligated to
repay the Other Indemnitor for all amounts so paid or reimbursed to the extent that the Company has an obligation to indemnify Indemnitee for such Expenses or Other Liabilities hereunder. 

4.    Partial Indemnification. If Indemnitee is entitled under any provision of this Agreement to
indemnification by the Company for some or a portion of any Expenses or Other Liabilities but not entitled, however, to indemnification for the total amount of such Expenses or Other Liabilities, the Company shall nevertheless indemnify Indemnitee
for such total amount except as to the portion thereof for which indemnification is prohibited by the provisions of the DGCL. In any review or Proceeding to determine the extent of indemnification, the Company shall bear the burden to
establish, by clear and convincing evidence, the lack of a successful resolution of a particular claim, issue or matter and which amounts sought in indemnity are allocable to claims, issues or matters which were not successfully resolved. 

5.    Liability Insurance. So long as Indemnitee shall continue to serve the Company or a Subsidiary or
Affiliate of the Company as an Indemnifiable Person and thereafter so long as Indemnitee shall be subject to any possible claim or threatened, pending or completed Proceeding as a result of an Indemnifiable Event, the Company shall use reasonable
efforts to maintain in full force and effect for the benefit of Indemnitee as an insured (i) liability insurance issued by one or more reputable insurers and having the policy amount and deductible deemed appropriate by the Board and providing in
all respects coverage at least comparable to and in the same amount as that provided to the Chairman of the Board or the Chief Executive Officer of the Company and (ii) any replacement or substitute policies issued by one or more reputable insurers
providing in all respects coverage at least comparable to and in the same amount as that being provided to the Chairman of the Board or the Chief Executive Officer of the Company. The purchase, establishment and maintenance of any such
insurance or other arrangements shall not in any way limit or affect the rights and obligations of the Company or of Indemnitee under this Agreement except as expressly provided herein, and the execution and delivery of this Agreement by the Company
and Indemnitee shall not in any way limit or affect the rights and obligations of the 

  
 4 

 
Company or the other party or parties thereto under any such insurance or other arrangement. In the event of a Change in Control subsequent to the date of this Agreement, or the Company’s
becoming insolvent, including being placed into receivership or entering the federal bankruptcy process, the Company shall maintain in force any directors’ and officers’ liability insurance policies then maintained by the Company in
providing insurance in respect of Indemnitee, for a period of six years thereafter. 
 6.    Mandatory
Advancement of Expenses. If requested by Indemnitee, the Company shall advance prior to the final disposition of the Proceeding all Expenses reasonably incurred by Indemnitee in connection with (including in preparation for) a Proceeding
related to an Indemnifiable Event. Indemnitee hereby undertakes to repay such amounts advanced if, and only if and to the extent that, it shall ultimately be determined that Indemnitee is not entitled to be indemnified by the Company under the
provisions of this Agreement, the DGCL, and no additional form of undertaking with respect to such obligation to repay shall be required. The advances to be made hereunder shall be paid by the Company to Indemnitee or directly to a third party
designated by Indemnitee within thirty (30) days following delivery of a written request therefor by Indemnitee to the Company. Indemnitee’s undertaking to repay any Expenses advanced to Indemnitee hereunder shall be unsecured and shall
not be subject to the accrual or payment of any interest thereon. In the event that Indemnitee’s request for the advancement of expenses shall be accompanied by an affidavit of counsel to Indemnitee to the effect that such counsel has reviewed
such Expenses and that such Expenses are reasonable in such counsel’s view, then such expenses shall be deemed reasonable in the absence of clear and convincing evidence to the contrary. 

7.    Notice and Other Indemnification Procedures. 

(a)    Notification. Promptly after receipt by Indemnitee of notice of the commencement of or the threat
of commencement of any Proceeding, Indemnitee shall, if Indemnitee believes that indemnification or advancement of Expenses with respect thereto may be sought from the Company under this Agreement, notify the Company of the commencement or threat of
commencement thereof. However, a failure so to notify the Company promptly following Indemnitee’s receipt of such notice shall not relieve the Company from any liability that it may have to Indemnitee except to the extent that the Company
is materially prejudiced in its defense of such Proceeding as a result of such failure. 
 (b)    Insurance
and Other Matters. If, at the time of the receipt of a notice of the commencement of a Proceeding pursuant to Section 7(a) above, the Company has director and officer liability insurance in effect, the Company shall give prompt notice of
the commencement of such Proceeding to the issuers in accordance with the procedures set forth in the respective policies. The Company shall thereafter take all reasonable action to cause such insurers to pay, on behalf of Indemnitee, all
amounts payable as a result of such Proceeding in accordance with the terms of such insurance policies. 

(c)    Assumption of Defense. In the event the Company shall be obligated to advance the Expenses for
any Proceeding against Indemnitee, the Company, if deemed appropriate by the Company, shall be entitled to assume the defense of such Proceeding as provided herein. Such defense by the Company may include the representation of two or more

  
 5 

 
parties by one attorney or law firm as permitted under the ethical rules and legal requirements related to joint representations. Following delivery of written notice to Indemnitee of the
Company’s election to assume the defense of such Proceeding, the approval by Indemnitee (which approval shall not be unreasonably withheld) of counsel designated by the Company and the retention of such counsel by the Company, the Company will
not be liable to Indemnitee under this Agreement for any fees and expenses of counsel subsequently incurred by Indemnitee with respect to the same Proceeding. If (A) the employment of counsel by Indemnitee has been previously authorized by the
Company, (B) Indemnitee shall have notified the Board in writing that Indemnitee has reasonably concluded that there is likely to be a conflict of interest between the Company and Indemnitee in the conduct of any such defense or (C) the Company
fails to employ counsel to assume the defense of such Proceeding, the fees and expenses of Indemnitee’s counsel shall be subject to indemnification and/or advancement pursuant to the terms of this Agreement. Nothing herein shall prevent
Indemnitee from employing counsel for any such Proceeding at Indemnitee’s expense. 

(d)    Settlement. The Company shall not be liable to indemnify Indemnitee under this Agreement or
otherwise for any amounts paid in settlement of any Proceeding effected without the Company’s written consent; provided, however, that if a Change in Control has occurred subsequent to the date of this Agreement, the Company shall be liable for
indemnification of Indemnitee for amounts paid in settlement if the Independent Counsel has approved the settlement. Neither the Company nor any Subsidiary or Affiliate shall enter into a settlement of any Proceeding that might result in the
imposition of any Expense, Other Liability, penalty, limitation or detriment on Indemnitee, whether indemnifiable under this Agreement or otherwise, without Indemnitee’s written consent. Neither the Company nor Indemnitee shall
unreasonably withhold consent from any settlement of any Proceeding. The Company shall promptly notify Indemnitee upon the Company’s receipt of an offer to settle, or if the Company makes an offer to settle, any Proceeding, and provide
Indemnitee with a reasonable amount of time to consider such settlement, in the case of any such settlement for which the consent of Indemnitee would be required hereunder. The Company shall not, on its own behalf, settle any part of any
Proceeding to which Indemnitee is a party with respect to other parties (including the Company) without the written consent of Indemnitee if any portion of the settlement is to be funded from insurance proceeds unless approved by a majority of
the Independent Directors, provided that this sentence shall cease to be of any force and effect if it has been determined in accordance with this Agreement that Indemnitee is not entitled to indemnification hereunder with respect to such Proceeding
or if the Company’s obligations hereunder to Indemnitee with respect to such Proceeding have been fully discharged.     

8.    Determination of Right to Indemnification. 

(a)    Success on the Merits or Otherwise. To the extent that Indemnitee has been successful on the
merits or otherwise in defense of any Proceeding referred to in Section 3(a) above or in the defense of any claim, issue or matter described therein, the Company shall indemnify Indemnitee against Expenses actually and reasonably incurred in
connection therewith. 

  
 6 

 (b)    Indemnification in Other Situations. In the event
that Section 8(a) is inapplicable, the Company shall also indemnify Indemnitee if Indemnitee has not failed to meet the applicable standard of conduct for indemnification. 

(c)    Forum. Indemnitee shall be entitled to select the forum in which determination of whether or not
Indemnitee has met the applicable standard of conduct shall be decided, and such election will be made from among the following: 

a.    Those members of the Board who are Independent Directors even though less than a quorum; 

b.    A committee of Independent Directors designated by a majority vote of Independent Directors, even though
less than a quorum; or 
 c.    Independent Counsel selected by Indemnitee and approved by the Board, which
approval may not be unreasonably withheld, which counsel shall make such determination in a written opinion. 
 If Indemnitee is an officer
or a director of the Company at the time that Indemnitee is selecting the forum, then Indemnitee shall not select Independent Counsel as such forum unless there are no Independent Directors or unless the Independent Directors agree to the selection
of Independent Counsel as the forum. 
 The selected forum shall be referred to herein as the “Reviewing
Party”. Notwithstanding the foregoing, following any Change in Control subsequent to the date of this Agreement, the Reviewing Party shall be Independent Counsel selected in the manner provided in c. above. 

(d)    As soon as practicable, and in no event later than thirty (30) days after receipt by the Company of written
notice of Indemnitee’s choice of forum pursuant to Section 8(c) above, the Company and Indemnitee shall each submit to the Reviewing Party such information as they believe is appropriate for the Reviewing Party to consider. The Reviewing
Party shall arrive at its decision within a reasonable period of time following the receipt of all such information from the Company and Indemnitee, but in no event later than thirty (30) days following the receipt of all such information, provided
that the time by which the Reviewing Party must reach a decision may be extended by mutual agreement of the Company and Indemnitee. All Expenses associated with the process set forth in this Section 8(d), including but not limited to the
Expenses of the Reviewing Party, shall be paid by the Company. 
 (e)    Delaware Court of
Chancery. Notwithstanding a final determination by any Reviewing Party that Indemnitee is not entitled to indemnification with respect to a specific Proceeding, Indemnitee shall have the right to apply to the Court of Chancery, for the
purpose of enforcing Indemnitee’s right to indemnification pursuant to this Agreement. 

(f)    Expenses. The Company shall indemnify Indemnitee against all Expenses incurred by Indemnitee in
connection with any hearing or Proceeding under this Section 8 involving Indemnitee and against all Expenses and Other Liabilities incurred by Indemnitee in connection with any other Proceeding between the Company and Indemnitee involving the
interpretation or enforcement of the rights of Indemnitee under this Agreement unless a court of competent jurisdiction finds that each of the material claims of Indemnitee in any such Proceeding was frivolous or made in bad faith. 

  
 7 

 (g)    Determination of “Good Faith”. For
purposes of any determination of whether Indemnitee acted in “good faith” Indemnitee shall be deemed to have acted in good faith if in taking or failing to take the action in question Indemnitee relied on the records or books of account of
the Company or a Subsidiary or Affiliate, including financial statements, or on information, opinions, reports or statements provided to Indemnitee by the officers or other employees of the Company or a Subsidiary or Affiliate in the course of their
duties, or on the advice of legal counsel for the Company or a Subsidiary or Affiliate, or on information or records given or reports made to the Company or a Subsidiary or Affiliate by an independent certified public accountant or by an appraiser
or other expert selected by the Company or a Subsidiary or Affiliate, or by any other person (including legal counsel, accountants and financial advisors) as to matters Indemnitee reasonably believes are within such other person’s professional
or expert competence and who has been selected with reasonable care by or on behalf of the Company or a Subsidiary or Affiliate. In connection with any determination as to whether Indemnitee is entitled to be indemnified hereunder, or to
advancement of expenses, the Reviewing Party or court shall presume that Indemnitee has satisfied the applicable standard of conduct and is entitled to indemnification or advancement of Expenses, as the case may be, and the burden of proof shall be
on the Company to establish, by clear and convincing evidence, that Indemnitee is not so entitled. The provisions of this Section 8(g) shall not be deemed to be exclusive or to limit in any way the other circumstances in which Indemnitee may be
deemed to have met the applicable standard of conduct set forth in this Agreement. In addition, the knowledge and/or actions, or failures to act, of any other person serving the Company or a Subsidiary or Affiliate as an Indemnifiable Person
shall not be imputed to Indemnitee for purposes of determining the right to indemnification hereunder.

9.    Exceptions. Any other provision herein to the contrary notwithstanding, 

(a)    Claims Initiated by Indemnitee. The Company shall not be obligated pursuant to the terms of this
Agreement to indemnify or advance Expenses to Indemnitee with respect to Proceedings or claims initiated or brought voluntarily by Indemnitee and not by way of defense, except (1) with respect to Proceedings brought to establish or enforce a right
to indemnification under this Agreement, any other statute or law, as permitted under Section 145, or otherwise, (2) where the Board has consented to the initiation of such Proceeding, or (3) with respect to Proceedings brought to discharge
Indemnitee’s fiduciary responsibilities, whether under ERISA or otherwise, but such indemnification or advancement of Expenses may be provided by the Company in specific cases if the Board finds it to be appropriate; or 

(b)    Actions Based on Federal Statutes Regarding Profit Recovery and Return of Bonus Payments. The
Company shall not be obligated pursuant to the terms of this Agreement to indemnify Indemnitee on account of (i) any suit in which judgment is rendered against Indemnitee for an accounting of profits made from the purchase or sale by Indemnitee of
securities of the Company pursuant to the provisions of Section 16(b) of the Securities Exchange Act of l934 and amendments thereto or similar provisions of any federal, state or local statutory law, or (ii) any reimbursement of the Company by the
Indemnitee of any bonus or other incentive-based or equity-based compensation or of any profits realized by the Indemnitee from 

  
 8 

 
the sale of securities of the Company, as required in each case under the Exchange Act (including any such reimbursements that arise from an accounting restatement of the Company pursuant to
Section 304 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”), or the payment to the Company of profits arising from the purchase and sale by Indemnitee of securities in violation of Section 306 of the Sarbanes-Oxley Act); or

 (c)    Unlawful Indemnification. The Company shall not be obligated pursuant to the terms of this
Agreement to indemnify Indemnitee for Other Liabilities if such indemnification is prohibited by law as determined by a court of competent jurisdiction in a final adjudication not subject to further appeal. 

10.    Non-exclusivity. The provisions for indemnification and advancement of Expenses set forth in
this Agreement shall not be deemed exclusive of any other rights which Indemnitee may have under any provision of law, the Company’s Certificate of Incorporation or Bylaws, the vote of the Company’s stockholders or disinterested directors,
other agreements, or otherwise, both as to acts or omissions in his or her official capacity and to acts or omissions in another capacity while serving the Company or a Subsidiary or Affiliate as an Indemnifiable Person and Indemnitee’s rights
hereunder shall continue after Indemnitee has ceased serving the Company or a Subsidiary or Affiliate as an Indemnifiable Person and shall inure to the benefit of the heirs, executors and administrators of Indemnitee. 

11.    Severability. If any provision or provisions of this Agreement shall be held to be invalid,
illegal or unenforceable for any reason whatsoever, (i) the validity, legality and enforceability of the remaining provisions of the Agreement (including, without limitation, all portions of any paragraphs of this Agreement containing any such
provision held to be invalid, illegal or unenforceable, that are not themselves invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby, and (ii) to the fullest extent possible, the provisions of this Agreement
(including, without limitation, all portions of any paragraphs of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that are not themselves invalid, illegal or unenforceable) shall be construed so as to give
effect to the intent manifested by the provision held invalid, illegal or unenforceable. 
 12.    
Supersession, Modification and Waiver. This Agreement supersedes any prior indemnification agreement between the Indemnitee and the Company, its Subsidiaries or its Affiliates. If the Company and Indemnitee have previously entered into
an indemnification agreement providing for the indemnification of Indemnitee by the Company, parties entry into this Agreement shall be deemed to amend and restate such prior agreement to read in its entirety as, and be superseded by, this
Agreement. No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a
waiver of any other provision hereof (whether or not similar) and except as expressly provided herein, no such waiver shall constitute a continuing waiver. 

13.    Successors and Assigns. The terms of this Agreement shall bind, and shall inure to the benefit
of, the successors and assigns of the parties hereto. 

  
 9 

 14.    Notice. All notices, requests, demands and other
communications under this Agreement shall be in writing and shall be deemed duly given (i) if delivered by hand and a receipt is provided by the party to whom such communication is delivered, (ii) if mailed by certified or registered mail with
postage prepaid, return receipt requested, on the signing by the recipient of an acknowledgement of receipt form accompanying delivery through the U.S. mail, (iii) personal service by a process server, or (iv) delivery to the recipient’s
address by overnight delivery (e.g., FedEx, UPS or DHL) or other commercial delivery service. Addresses for notice to either party are as shown on the signature page of this Agreement, or as subsequently modified by written notice complying
with the provisions of this Section 14. Delivery of communications to the Company with respect to this Agreement shall be sent to the attention of the Company’s General Counsel. 

15.    No Presumptions. For purposes of this Agreement, the termination of any Proceeding, by judgment,
order, settlement (whether with or without court approval) or conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that Indemnitee did not meet any particular standard of conduct or have any
particular belief or that a court has determined that indemnification is not permitted by applicable law or otherwise. In addition, neither the failure of the Company or a Reviewing Party to have made a determination as to whether Indemnitee
has met any particular standard of conduct or had any particular belief, nor an actual determination by the Company or a Reviewing Party that Indemnitee has not met such standard of conduct or did not have such belief, prior to the commencement of
Proceedings by Indemnitee to secure a judicial determination by exercising Indemnitee’s rights under Section 8(e) of this Agreement shall be a defense to Indemnitee’s claim or create a presumption that Indemnitee has failed to meet any
particular standard of conduct or did not have any particular belief or is not entitled to indemnification under applicable law or otherwise. 

16.    Survival of Rights. The rights conferred on Indemnitee by this Agreement shall continue after
Indemnitee has ceased to serve the Company or a Subsidiary or Affiliate of the Company as an Indemnifiable Person and shall inure to the benefit of Indemnitee’s heirs, executors and administrators. 

17.    Subrogation and Contribution.

(a)     In the event of payment under this Agreement, the Company shall be subrogated to the extent of such payment
to all of the rights of recovery of Indemnitee, who shall execute all documents required and shall do all acts that may be necessary to secure such rights and to enable the Company effectively to bring suit to enforce such rights.

(b)    To the fullest extent permissible under applicable law, if the indemnification provided for in this
Agreement is unavailable to Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by or on behalf of Indemnitee, whether for judgments, fines, penalties, excise taxes, amounts
paid or to be paid in settlement and/or for Expenses, in connection with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such Proceeding
in order to reflect (i) the relative benefits received by the Company and Indemnitee as a result of the event(s) and/or transaction(s) 

  
 10 

 
giving cause to such Proceeding; and/or (ii) the relative fault of the Company (and its directors, officers, employees and agents) and Indemnitee in connection with such event(s) and/or
transaction(s). 
 18.    Specific Performance, Etc. The parties recognize that if any provision of
this Agreement is violated by the Company, Indemnitee may be without an adequate remedy at law. Accordingly, in the event of any such violation, Indemnitee shall be entitled, if Indemnitee so elects, to institute Proceedings, either in law or
at equity, to obtain damages, to enforce specific performance, to enjoin such violation, or to obtain any relief or any combination of the foregoing as Indemnitee may elect to pursue. 

19.    Counterparts. This Agreement may be executed in counterparts, each of which shall for all
purposes be deemed to be an original but all of which together shall constitute one and the same agreement. Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of
this Agreement. 
 20.    Headings. The headings of the sections and paragraphs of this Agreement are
inserted for convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction or interpretation thereof. 

21.    Governing Law. This Agreement shall be governed exclusively by and construed according to the
laws of the State of Delaware, as applied to contracts between Delaware residents entered into and to be performed entirely with Delaware. 

22.    Consent to Jurisdiction. The Company and Indemnitee each hereby irrevocably consent to the
jurisdiction of the courts of the State of Delaware for all purposes in connection with any Proceeding which arises out of or relates to this Agreement. 

[ Signature Page Follows] 

  
 11 

 The parties hereto have entered into this Indemnity Agreement effective as of the date first
above written. 
  

					
		 	 KALVISTA PHARMACEUTICALS, INC.

			
		 	 By:
	 	  

		 	 Name:
	 	  

		 	 Its:
	 	  

		 	  
  

INDEMNITEE

		
		 	  

		 	 [Name]

		
	 Address:10.1

 

Exhibit 10.1

Amendment
# 2 to the

License, Development and
Commercialization Agreement

Between

Echo Therapeutics,
Inc.

And

Medical
Technologies Innovations, Asia,
Ltd.

1 

EXECUTIVE
SUMMARY

1.1            
Scope. This
amendment covers the activities necessary to support the Chinese
commercialization of the “Core 2+ and “Generation
3” versions of the Echo CGM system, as defined below. This
Amendment # 2 will take effect, and is conditioned upon receipt of
$500,000 in additional bridge loans on or before November
30th.

1.2                Amended
Terms. The terms in the Original Agreement remain in force,
except as described below.

1.3                Product
Definition. The definition of “Product”
contained in Section 1.1.59 is amended to include the
following:

 

	

Release

 

	

Device

 

	

Description

 

	

Echo
Deliverables

 

	

MTIA
Responsibilities

 

	

Core
2+

 

	

System

 

	

Support
as needed plus deliverables listed below. Evaluation and testing of
MTIA produced materials, as needed.

 

	

Prototype
construction, preliminary clinical testing in China. Manufacturing,
CFDA clinical testing, regulatory approval,
commercialization.

 

	

Sensor
Module & Target Base

 

	

Gen 1
CoPhthal Electrode, dried hydrogel, plastic case. Target Base with
adhesive.

 

	

Design
changes, test reports.

 

	

Final
changes to design and testing as needed.

 

	

Disposable
Kit

 

	

Disposable package,
containing the single use devices. Updates include new Tip, BZK
wipe, Reference ring & labeling

 

	

None.

 

	

Update
to Bill of Materials, contents, packaging & labeling. Shelf
life & other testing as needed.

 

	

Transmitter

 

	

Bluetooth
transmitter and embedded firmware.

 

	

Firmware executable
program and PC based test program.

 

	

Testing
as needed.

 

	

Glucose
Algorithm

 

	

Signal
processing software and configuration parameters.

 

	

Executable program
and baseline configuration parameters. PC based test
tool.

 

	

Final
configuration parameters, testing as needed.

 

	

Exfoliator

 

	

Skin
exfoliator, with embedded control firmware and configuration
parameters.

Battery
charger.

 

	

Design
documentation, sample prototypes. Firmware executable program,
configuration parameters and PC based test program.

 

	

Final
configuration parameters, testing as needed. Exfoliator tip
production.

Battery
charger design, development and testing.

 

	

API

 

	

Application
Programming Interface, running on Android

 

	

Executable software
(Android), test reports and interface document.

 

	

None.

 

	

App

 

	

CGM
Application with Graphical User Interface.

 

	

Example
English App with source code and executable (Android).

 

	

Software
development of Chinese App, Testing as needed.

 

 

 

 

 

	

Release

 

	

Device

	

Description

 

	

Echo
Deliverables

 

	

MTIA
Responsibilities

 

	

Generation 3 and
all future generations of our CGM product(s)

 

	

System

 

	

Requirements,
design, implementation, testing and preliminary clinical testing.
Software and algorithm design.

Evaluation and
testing of MTIA produced materials, as needed.

 

	

User
documentation, Shipping packaging & labeling. Preliminary
clinical testing in China. Manufacturing, CFDA clinical testing,
regulatory approval, commercialization.

 

	

Sensor
Module & Target Base

 

	

Electrode, Wet
Hydrogel and plastic carrier

 

	

Design
documentation, Design test reports, pilot production, sample
prototypes

 

	

Plastic
part tooling & part

manufacturing.

 

	

Disposable
Kit

 

	

Sterile, disposable
package, containing the single use devices (Tip, Target Base,
Sensor, Hydrogel, Tray, Packaging)

 

	

Design
documentation, Design test reports, pilot production, sample
prototypes

 

	

Plastic
part tooling & part

manufacturing.

 

	

Transmitter

 

	

Reusable, battery
operated transmitter and embedded firmware

 

	

Design
documentation, Design test reports and sample prototypes. Firmware
executable program and PC based test program.

 

	

Plastic
part tooling & part

manufacturing

 

	

Glucose
Algorithm

 

	

Signal
processing software that produces glucose values

 

	

Executable software
and configuration parameters. Design test reports

 

	
 

	

Exfoliator

 

	

Self-use
Exfoliator, with embedded firmware.

 

	

Design
documentation, Design test reports and sample prototypes. Firmware
executable program and PC based test program.

 

	

Plastic
part tooling & part

manufacturing

 

	

API

 

	

Application
Programming Interface, running on Android

 

	

Executable software
(Android), test reports and interface document.

 

	

None.

 

	

App

 

	

Chinese
CGM Application

 

	

Example
English App with source code and executable (Android).

 

	

Software
development of Chinese App, Testing as needed.

 

2 

DEVELOPMENT
PROJECT

2.1                Work
Plan and Overview. Echo and MTIA will cooperate in the
development of a project Overview and a more detailed Work Plan.
This work plan will describe the responsibilities of each company
for the development of the devices described above, in
“Product Definition”. In the event that a change is
needed in the definition of these deliverables, this will be made
with mutual consent, in an update to the work plan.

 

 

2.2                Software
Development. Echo will provide an Application Programming
Interface (API) to facilitate the development by MTIA of
application software for both Core 2+ and Generation 3. Echo will
develop and provide source code for an example application using
the API. The MTIA application software will be developed by MTIA
based on requirements MTIA defines. Echo will provide executable
versions of the software for the Exfoliator, Transmitter and
API.

2.3                Technology
Transfer. Echo will provide documentation and training to
MTIA to ensure that MTIA has the knowledge necessary to manufacture
the devices described in the “Product Definition”
above.

2.4               
Development
Schedules. Both companies will publish to each other, Gantt
charts showing the activities and end dates needed to produce the
deliverables described in the work plan

2.5             
   
Status Reports.
Both companies will publish bi-weekly status reports to each other,
describing the progress, issues and any significant schedule
updates.

2.6      
           Conference Calls
-TBD

3 

PAYMENTS

The
terms of the Original Agreement apply with the following
exceptions:

3.1                Reimbursement.
There shall be up to $2,000,000 of reimbursement for direct out of
pocket expenses, subject to submission of appropriate documentation
for review and approval by the Company and outside independent
auditors hired by the Company for work done by MTIA, or their
affiliates, on our CGM product in development to date of this
agreement. Reimbursement will be made in the form of a promissory
note payable to MTIA upon consummation of a convertible debt
financing led by MTIA or their affiliates in excess of $5,000,000
of gross proceeds. The form of the promissory note will be the same
form as those issued in the financing. No further reimbursement
will be made by Echo to MTIA for costs involved in the development
of products to obtain CFDA approval or for commercial deployment.
If a convertible debt financing cannot be led by MTIA or their
affiliates, Echo will only reimburse up to a maximum of $1,500,000
upon CFDA approval of the products through the same promissory note
as stated in accordance with the terms of the Original
Agreement.

3.2                Prototypes.
MTIA will reimburse Echo for the real and actual costs of producing
and shipping prototype samples delivered to MTIA clinical testing,
demonstration and other purposes, for the products described above
in the “Product Definition”.

3.3                Plastic
Parts and Tooling. MTIA will provide the tooling for the
plastic parts needed for the products described above in the
“Product Definition”. MTIA or their affiliates will
also be responsible to provide these products to Echo for design
testing, clinical testing, demonstration and other purposes. Echo
will reimburse MTIA or their affiliates for the real and actual
costs of producing and shipping manufactured parts for these
products.

4.
NOTICES

4.1           

All notices to Echo
shall be sent to:

 

Echo
Therapeutics, Inc.

295
Foster Street

Littleton, MA
01460

Attention: Chief
Financial Officer

with a
copy to:

Kevin
W. Waite, Esq.

Moomjian, Waite
& Coleman, LLP

100
Jericho Quadrangle, Suite 208

Jericho, NY
11753

 

 

 

IN
WITNESS WHEREOF, the Parties, intending to be legally bound hereby,
have caused their duly authorized representatives to execute this
Agreement as of the Effective Date.

 

ECHO
THERAPEUTICS, INC.

 

By:      
/s/ Alan W.
Schoenbart________

Name: 
Alan W.
Schoenbart

Title:
   CFO

 

 

MEDICAL
TECHNOLOGIES INNOVATION ASIA, LTD.

 

By:      
/s/ Bai
Ge__________________

Name: 
Bai Ge

Title:
   Managing
Director

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00264-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00264-of-00352.parquet"}]]